101 related articles for article (PubMed ID: 25208228)
1. Overlapping between CYP3A4 and CYP3A7 expression in the fetal human liver during development.
Fanni D; Fanos V; Ambu R; Lai F; Gerosa C; Pampaloni P; Van Eyken P; Senes G; Castagnola M; Faa G
J Matern Fetal Neonatal Med; 2015 Jul; 28(11):1291-1295. PubMed ID: 25208228
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.
Hakkola J; Raunio H; Purkunen R; Saarikoski S; Vähäkangas K; Pelkonen O; Edwards RJ; Boobis AR; Pasanen M
Biol Neonate; 2001; 80(3):193-201. PubMed ID: 11585982
[TBL] [Abstract][Full Text] [Related]
3. Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors.
Betts S; Björkhem-Bergman L; Rane A; Ekström L
Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):261-6. PubMed ID: 25689036
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 3A: ontogeny and drug disposition.
de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
Clin Pharmacokinet; 1999 Dec; 37(6):485-505. PubMed ID: 10628899
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma.
Fanni D; Manchia M; Lai F; Gerosa C; Ambu R; Faa G
Eur J Histochem; 2016 Apr; 60(2):2614. PubMed ID: 27349315
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 genetic polymorphism in neonatal drug metabolism: role and practical consequences towards a new drug culture in neonatology.
Fanni D; Ambu R; Gerosa C; Nemolato S; Castagnola M; Van Eyken P; Faa G; Fanos V
Int J Immunopathol Pharmacol; 2014; 27(1):5-13. PubMed ID: 24674673
[TBL] [Abstract][Full Text] [Related]
7. Developmental regulation of CYP3A4 and CYP3A7 in Chinese Han population.
He H; Nie YL; Li JF; Meng XG; Yang WH; Chen YL; Wang SJ; Ma X; Kan QC; Zhang LR
Drug Metab Pharmacokinet; 2016 Dec; 31(6):433-444. PubMed ID: 27727071
[TBL] [Abstract][Full Text] [Related]
8. Identification of CYP3A7 for glyburide metabolism in human fetal livers.
Shuster DL; Risler LJ; Prasad B; Calamia JC; Voellinger JL; Kelly EJ; Unadkat JD; Hebert MF; Shen DD; Thummel KE; Mao Q
Biochem Pharmacol; 2014 Dec; 92(4):690-700. PubMed ID: 25450675
[TBL] [Abstract][Full Text] [Related]
9. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver.
Schuetz JD; Beach DL; Guzelian PS
Pharmacogenetics; 1994 Feb; 4(1):11-20. PubMed ID: 8004129
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the CYP3A4 and CYP3A7 promoters by members of the nuclear factor I transcription factor family.
Riffel AK; Schuenemann E; Vyhlidal CA
Mol Pharmacol; 2009 Nov; 76(5):1104-14. PubMed ID: 19706729
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal Livers.
Vyhlidal CA; Bi C; Ye SQ; Leeder JS
Drug Metab Dispos; 2016 Jul; 44(7):1020-6. PubMed ID: 26772622
[TBL] [Abstract][Full Text] [Related]
12. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta.
Schuetz JD; Kauma S; Guzelian PS
J Clin Invest; 1993 Aug; 92(2):1018-24. PubMed ID: 8349787
[TBL] [Abstract][Full Text] [Related]
13. Variability of CYP3A7 expression in human fetal liver.
Leeder JS; Gaedigk R; Marcucci KA; Gaedigk A; Vyhlidal CA; Schindel BP; Pearce RE
J Pharmacol Exp Ther; 2005 Aug; 314(2):626-35. PubMed ID: 15845858
[TBL] [Abstract][Full Text] [Related]
14. CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.
Zia H; Murray GI; Vyhlidal CA; Leeder JS; Anwar AE; Bui MM; Ahmed AA
Int J Exp Pathol; 2015 Apr; 96(2):81-6. PubMed ID: 25670065
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7.
Godamudunage MP; Grech AM; Scott EE
Drug Metab Dispos; 2018 Sep; 46(9):1329-1337. PubMed ID: 29991575
[TBL] [Abstract][Full Text] [Related]
16. Developmental expression of the major human hepatic CYP3A enzymes.
Stevens JC; Hines RN; Gu C; Koukouritaki SB; Manro JR; Tandler PJ; Zaya MJ
J Pharmacol Exp Ther; 2003 Nov; 307(2):573-82. PubMed ID: 12975492
[TBL] [Abstract][Full Text] [Related]
17. CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele.
Sim SC; Edwards RJ; Boobis AR; Ingelman-Sundberg M
Pharmacogenet Genomics; 2005 Sep; 15(9):625-31. PubMed ID: 16041241
[TBL] [Abstract][Full Text] [Related]
18. Identification of Selective CYP3A7 and CYP3A4 Substrates and Inhibitors Using a High-Throughput Screening Platform.
Kabir M; Padilha EC; Shah P; Huang R; Sakamuru S; Gonzalez E; Ye L; Hu X; Henderson MJ; Xia M; Xu X
Front Pharmacol; 2022; 13():899536. PubMed ID: 35847040
[TBL] [Abstract][Full Text] [Related]
19. Loss of CYP3A7 gene induction by 1,25-dihydroxyvitamin D3 is caused by less binding of VDR to the proximal ER6 in CYP3A7 gene.
Hara H; Yasunami Y; Adachi T
Biochem Biophys Res Commun; 2004 Sep; 321(4):909-15. PubMed ID: 15358113
[TBL] [Abstract][Full Text] [Related]
20. The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture.
Greuet J; Pichard L; Bonfils C; Domergue J; Maurel P
Biochem Biophys Res Commun; 1996 Aug; 225(2):689-94. PubMed ID: 8753820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
